Compare Aegon Ltd. (AEG) vs Recursion Pharmaceuticals Inc (RXRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Aegon Ltd. vs Recursion Pharmaceuticals Inc — how do they compare? Aegon Ltd. trades at $9.44 (market cap $14.01B), while Recursion Pharmaceuticals Inc trades at $3.36 (market cap $1.81B). The key difference: Aegon Ltd. is far larger — about 7.7× Recursion Pharmaceuticals Inc's market cap, and Aegon Ltd. pays a 4.94% dividend while Recursion Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| AEG | RXRX | |
|---|---|---|
Market Cap | $14.01B | $1.81B |
Sector | Financials | Health |
52-Week High | $9.53 | $6.79 |
52-Week Low | $6.79 | $2.84 |
Enterprise Value | $15.16B | $1.33B |
Dividend Yield | 4.94% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Aegon Ltd.
Aegon is a Netherlands-headquartered insurance company with core operations that stretch across the U.S., Netherlands, and United Kingdom. The business also holds peripheral ventures in Spain, Portugal, Brazil, and China.
Read more on AEG →About Recursion Pharmaceuticals Inc
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.
Read more on RXRX →
